The generation of the first CFTR−/− rat using zinc finger nuclease technology suggests a clear path to other CF animal models with specific mutations relevant to therapeutic development, including animals that express F508del or CFTR premature truncations alleles. This evidence concerns the gene CFTR and cystic fibrosis.